PortfoliosLab logoPortfoliosLab logo
INMB vs. AIRO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

INMB vs. AIRO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in INmune Bio, Inc. (INMB) and AIRO Group Holdings, Inc (AIRO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, INMB achieves a -8.97% return, which is significantly lower than AIRO's 15.65% return.


INMB

1D
2.16%
1M
-5.96%
YTD
-8.97%
6M
-9.55%
1Y
-80.25%
3Y*
-43.47%
5Y*
-36.14%
10Y*

AIRO

1D
2.49%
1M
27.49%
YTD
15.65%
6M
14.25%
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

INMB vs. AIRO - Yearly Performance Comparison


2026 (YTD)2025
INMB
INmune Bio, Inc.
-8.97%-79.74%
AIRO
AIRO Group Holdings, Inc
15.65%-65.92%

Correlation

The correlation between INMB and AIRO is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (All Time)
Calculated using the full available price history since Jun 16, 2025

0.27

Fundamentals

Market Cap

INMB:

$37.75M

AIRO:

$223.99M

EPS

INMB:

-$1.61

AIRO:

$0.38

PB Ratio

INMB:

1.92

AIRO:

0.30

Total Revenue (TTM)

INMB:

$0.00

AIRO:

$90.91M

Gross Profit (TTM)

INMB:

-$108.00K

AIRO:

$54.42M

EBITDA (TTM)

INMB:

-$26.72M

AIRO:

-$28.77M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


INmune Bio, Inc.

AIRO Group Holdings, Inc

Return for Risk

INMB vs. AIRO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INMB
INMB Risk / Return Rank: 99
Overall Rank
INMB Sharpe Ratio Rank: 99
Sharpe Ratio Rank
INMB Sortino Ratio Rank: 88
Sortino Ratio Rank
INMB Omega Ratio Rank: 77
Omega Ratio Rank
INMB Calmar Ratio Rank: 44
Calmar Ratio Rank
INMB Martin Ratio Rank: 1818
Martin Ratio Rank

AIRO
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INMB vs. AIRO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for INmune Bio, Inc. (INMB) and AIRO Group Holdings, Inc (AIRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


INMBAIRODifference

Sharpe ratio

Return per unit of total volatility

-0.80

Sortino ratio

Return per unit of downside risk

-1.24

Omega ratio

Gain probability vs. loss probability

0.83

Calmar ratio

Return relative to maximum drawdown

-0.94

Martin ratio

Return relative to average drawdown

-1.07

INMB vs. AIRO - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


INMBAIRODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.80

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

-0.62

+0.40

Drawdowns

INMB vs. AIRO - Drawdown Comparison

The maximum INMB drawdown since its inception was -95.98%, which is greater than AIRO's maximum drawdown of -81.13%. Use the drawdown chart below to compare losses from any high point for INMB and AIRO.


Loading charts...

Drawdown Indicators


INMBAIRODifference

Max Drawdown

Largest peak-to-trough decline

-95.98%

-81.13%

-14.85%

Max Drawdown (1Y)

Largest decline over 1 year

-86.16%

Max Drawdown (3Y)

Largest decline over 3 years

-92.01%

Max Drawdown (5Y)

Largest decline over 5 years

-95.98%

Current Drawdown

Current decline from peak

-94.90%

-69.48%

-25.42%

Average Drawdown

Average peak-to-trough decline

-60.46%

-53.98%

-6.48%

Ulcer Index

Depth and duration of drawdowns from previous peaks

75.51%

Volatility

INMB vs. AIRO - Volatility Comparison


Loading charts...

Volatility by Period


INMBAIRODifference

Volatility (1M)

Calculated over the trailing 1-month period

21.76%

Volatility (6M)

Calculated over the trailing 6-month period

53.04%

Volatility (1Y)

Calculated over the trailing 1-year period

100.36%

99.90%

+0.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.95%

99.90%

-13.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

92.82%

99.90%

-7.08%

Dividends

INMB vs. AIRO - Dividend Comparison

Neither INMB nor AIRO has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

INMB vs. AIRO - Financials Comparison

This section allows you to compare key financial metrics between INmune Bio, Inc. and AIRO Group Holdings, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M202220232024202520260
48.28M
(INMB) Total Revenue
(AIRO) Total Revenue
Values in USD except per share items

Frequently Asked Questions


INMB and AIRO have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for INMB and AIRO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer